Main sponsors

​​​​​​About ANCHOR Diagnostics

ANCHOR Diagnostics is an agile and innovative medical diagnostics company committed to advancing healthcare. We specialize in molecular diagnostics for infectious diseases, providing high-speed test systems that enable laboratories to deliver accurate results in less than 60 minutes, including cutting-edge 30-minute PCR technology.

Founded in 2015, ANCHOR Diagnostics is an ISO 13485-certified, owner-managed company headquartered in Hamburg, Germany. Our solutions combine exceptional speed, precision, and reliability to optimize laboratory workflows, reduce turnaround times, and improve patient outcomes. With a strong focus on innovation and quality, reflecting our dedication to shaping the future of diagnostics.

ANCHOR Diagnostics

About AskBio Inc.

AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to steering gene therapy into a new era where it can transform the lives of a wider range of people living with rare and more common diseases. The company maintains a portfolio of clinical programs across a range of disease indications related to a single gene or multiple factors across cardiovascular, central nervous system, and neuromuscular conditions, with a clinical-stage pipeline that includes investigational therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease.

AskBio Inc.

​​​​​​About Cepheid GmbH

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. Cepheid’s GeneXpert^® systems and Xpert^® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, Tuberculosis and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings.

Cepheid GmbH

Gilead Sciences GmbH

Gilead Sciences is a global biopharmaceutical company dedicated to developing innovative therapies for life‑threatening diseases. For over three decades, the company has advanced transformative treatments across virology, oncology, and inflammation, combining scientific rigor with a strong commitment to global health. From individual patients to whole populations, Gilead is committed to delivering healthier futures for people and communities worldwide. Operating in more than 35 countries with over 17,000 employees, Gilead drives innovation while expanding access to life‑saving medicines through strategic partnerships and responsible operations.

RhineGene Germany GmbH, established in 2023, expands RhineGene’s presence in Europe by delivering high-quality molecular diagnostics solutions to clinical, research, and public-health laboratories. The company provides Real-Time PCR kits, nucleic acid extraction kits, rapid antigen test kits, automated extraction systems, and PCR instrumentation designed to support reliable and efficient diagnostics in line with EU IVDR standards.

As part of the RhineGene group and a subsidiary of Anatolia Geneworks, a leading manufacturer certified under ISO 9001:2015, ISO 13485:2016, and EU IVDR 2017/746, RhineGene Germany benefits from strong R&D capabilities, advanced production expertise, and a global network dedicated to improving patient care and public health.

Gilead Sciences GmbH

About RhineGene Germany GmbH

RhineGene Germany GmbH, established in 2023, expands RhineGene’s presence in Europe by delivering high-quality molecular diagnostics solutions to clinical, research, and public-health laboratories. The company provides Real-Time PCR kits, nucleic acid extraction kits, rapid antigen test kits, automated extraction systems, and PCR instrumentation designed to support reliable and efficient diagnostics in line with EU IVDR standards.

As part of the RhineGene group and a subsidiary of Anatolia Geneworks, a leading manufacturer certified under ISO 9001:2015, ISO 13485:2016, and EU IVDR 2017/746, RhineGene Germany benefits from strong R&D capabilities, advanced production expertise, and a global network dedicated to improving patient care and public health.

RhineGene Germany GmbH

About Seegene Germany GmbH

Seegene Germany, based in Düsseldorf, is the German subsidiary of Seegene Inc., headquartered in Seoul, South Korea. Since 2016, the company has focused on advancing innovative in-vitro diagnostics in Germany. Seegene is a global leader in molecular diagnostics, specializing in multiplex real-time PCR technologies built on patented platforms such as DPO™, TOCE™, and MuDT™. These solutions enable the simultaneous detection of up to 15 pathogens in a single test - efficient, precise, and reliable. Beyond assays, Seegene offers complete diagnostic workflows, from DNA extraction to automated PCR analysis and intelligent data interpretation.

Seegene Germany